Codex DNA, Inc. (DNAY) Cash Flow Annual - Discounting Cash Flows
DNAY
Codex DNA, Inc.
DNAY (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
Report Filing: 2024-11-07 2023-03-22 2022-03-23 2020-12-31
Net Income/Starting Line -7.97 -48.47 -38.96 -18.01
Cash From Operating Activities -3.21 -38.72 -36.7 -15.38
Depreciation and Amortization -0.044 1.67 0.908 1.46
Deferred Income Tax 0 0 0 0
Stock Based Compensation 1.88 3.73 1.09 0.043
Other Non-Cash Items 12.74 5.21 3.3 1.15
Changes in Working Capital -9.82 -0.855 -3.04 -0.02
Accounts Receivable 4.97 -2.19 -0.735 -0.774
Inventory 0.551 0.168 -1.46 0.111
Accounts Payable 0.091 1.16 4.39 0.142
Deferred Revenue -11.37 0.855 -5.23 0.501
Other Working Capital -4.06 -0.855 0 0
Cash From Investing Activities 71.97 -18.01 -15.04 -0.204
Investments in Property Plant and Equipment 1.91 -4.47 -1.85 -0.204
Payments for Acquisitions 0 0 0 0
Purchases of Securities 54.83 -77.43 0 0
Sales and Maturities of Investments 13.78 64.44 0 0
Other Investing Activities 1.44 -0.556 -13.19 0
Cash From Financing Activities -0.483 4.51 121.1 -0.096
Debt Repayment 0 0 0 0
Common Stock Issued 0.11 0.098 112.5 0
Common Stock Repurchased 0 0 0 0
Dividends Paid -1.8 0 0 0
Other Financing Activities 1.33 4.51 121.1 -0.096
Effect of Forex Changes on Cash -60.53 0 0 0
Net Change in Cash -21.1 -52.21 69.34 -15.68
Cash at Beginning of Period 24.92 82.81 13.46 29.14
Cash at End of Period 3.82 30.59 82.81 13.46
Free Cash Flow -1.29 -43.18 -38.55 -15.59
Operating Cash Flow -3.21 -38.72 -36.7 -15.38
Capital Expenditure 1.91 -4.47 -1.85 -0.204
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program